CORD-19:c654596857bce9cdd64ffc51842048643107348c / 392187-392361 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    There are no reports of fulminant and fatal hepatic failure after the start of Highly Active Antiretroviral Therapy (HAART) in an HIV subject without chronic viral hepatitis.

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T349","span":{"begin":0,"end":174},"obj":"Sentence"}],"text":"There are no reports of fulminant and fatal hepatic failure after the start of Highly Active Antiretroviral Therapy (HAART) in an HIV subject without chronic viral hepatitis."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T812","span":{"begin":44,"end":59},"obj":"Phenotype"},{"id":"T813","span":{"begin":158,"end":173},"obj":"Phenotype"}],"attributes":[{"id":"A812","pred":"hp_id","subj":"T812","obj":"http://purl.obolibrary.org/obo/HP_0001399"},{"id":"A813","pred":"hp_id","subj":"T813","obj":"http://purl.obolibrary.org/obo/HP_0006562"}],"text":"There are no reports of fulminant and fatal hepatic failure after the start of Highly Active Antiretroviral Therapy (HAART) in an HIV subject without chronic viral hepatitis."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1898","span":{"begin":158,"end":173},"obj":"Disease"},{"id":"T1899","span":{"begin":164,"end":173},"obj":"Disease"},{"id":"T18258","span":{"begin":158,"end":173},"obj":"Disease"},{"id":"T49911","span":{"begin":164,"end":173},"obj":"Disease"}],"attributes":[{"id":"A1898","pred":"mondo_id","subj":"T1898","obj":"http://purl.obolibrary.org/obo/MONDO_0006011"},{"id":"A1899","pred":"mondo_id","subj":"T1899","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A10069","pred":"mondo_id","subj":"T18258","obj":"http://purl.obolibrary.org/obo/MONDO_0006011"},{"id":"A98435","pred":"mondo_id","subj":"T49911","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"}],"text":"There are no reports of fulminant and fatal hepatic failure after the start of Highly Active Antiretroviral Therapy (HAART) in an HIV subject without chronic viral hepatitis."}